Please provide your email address to receive an email when new articles are posted on . Testosterone undecanoate injected at 8-week intervals for men with hypogonadism may reduce fluctuations and ...
"Combined Clomiphene and High-Dose Oral Testosterone Therapy in Hypogonadal Men: A Case Series" – This study, conducted by Dr. Andrew Sun, Grace Yoon BS, and Jimmy Vo BS, explores the effects of ...
Please provide your email address to receive an email when new articles are posted on . Oral testosterone undecanoate increased serum testosterone levels to 450 ng/dL for 92% of men. A clinically ...
TORONTO—Testosterone undecanoate administered every three months is a safe treatment for hypogonadal men, according to a four-year study. Parenteral testosterone undecanoate (TU) was administered to ...
MIAMI -- Oral testosterone replacement therapy (TRT) seemed safe and effective in men with testosterone deficiency, according to a meta-analysis. Among nine studies that looked at changes in serum ...
SAN DIEGO -- Long-term testosterone therapy was associated with sustained reductions in weight for men with hypogonadism and class III obesity, a researcher reported. In registry data on 76 patients, ...
Tlando is supplied as 112.5mg of testosterone undecanoate capsules. Tlando ™ (testosterone undecanoate) is now available for testosterone replacement therapy in adult males for conditions associated ...
RALEIGH, N.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. today announced a collaboration with Hims & Hers™, one of the largest digital health platforms for men, to make KYZATREX ...
JATENZO is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions Clarus plans to list this patent in ...
Partnership with AssistRx, the intelligent therapy initiation and patient support solutions provider, streamlines process for JATENZO prescription fulfillment and distribution to patients NORTHBROOK, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results